BOMBELLI, MICHELE
 Distribuzione geografica
Continente #
NA - Nord America 10.554
EU - Europa 5.170
AS - Asia 2.378
SA - Sud America 66
AF - Africa 20
Continente sconosciuto - Info sul continente non disponibili 14
OC - Oceania 9
Totale 18.211
Nazione #
US - Stati Uniti d'America 10.383
IT - Italia 1.072
DE - Germania 962
SG - Singapore 870
CN - Cina 803
SE - Svezia 785
IE - Irlanda 702
RU - Federazione Russa 577
UA - Ucraina 399
HK - Hong Kong 392
GB - Regno Unito 241
CA - Canada 159
FI - Finlandia 139
VN - Vietnam 85
FR - Francia 67
IN - India 65
ID - Indonesia 56
NL - Olanda 50
BR - Brasile 49
DK - Danimarca 48
AT - Austria 33
TR - Turchia 27
BE - Belgio 20
CZ - Repubblica Ceca 20
IR - Iran 15
RO - Romania 14
EU - Europa 11
JP - Giappone 10
CH - Svizzera 8
AU - Australia 7
KR - Corea 7
PH - Filippine 7
EC - Ecuador 6
LK - Sri Lanka 5
MX - Messico 5
PE - Perù 5
TH - Thailandia 5
ES - Italia 4
LT - Lituania 4
MY - Malesia 4
SK - Slovacchia (Repubblica Slovacca) 4
AE - Emirati Arabi Uniti 3
BD - Bangladesh 3
BJ - Benin 3
EE - Estonia 3
KE - Kenya 3
LA - Repubblica Popolare Democratica del Laos 3
PL - Polonia 3
PT - Portogallo 3
RS - Serbia 3
TW - Taiwan 3
UZ - Uzbekistan 3
BB - Barbados 2
CM - Camerun 2
DO - Repubblica Dominicana 2
GR - Grecia 2
HR - Croazia 2
HU - Ungheria 2
IL - Israele 2
LB - Libano 2
LV - Lettonia 2
MA - Marocco 2
MG - Madagascar 2
NZ - Nuova Zelanda 2
TN - Tunisia 2
VE - Venezuela 2
XK - ???statistics.table.value.countryCode.XK??? 2
ZA - Sudafrica 2
A2 - ???statistics.table.value.countryCode.A2??? 1
AM - Armenia 1
AR - Argentina 1
AZ - Azerbaigian 1
BG - Bulgaria 1
BO - Bolivia 1
CL - Cile 1
CR - Costa Rica 1
EG - Egitto 1
GY - Guiana 1
IQ - Iraq 1
KH - Cambogia 1
KZ - Kazakistan 1
MU - Mauritius 1
NP - Nepal 1
OM - Oman 1
PA - Panama 1
PK - Pakistan 1
SC - Seychelles 1
TT - Trinidad e Tobago 1
UG - Uganda 1
Totale 18.211
Città #
Ann Arbor 1.953
Woodbridge 944
Fairfield 824
Houston 758
Chandler 708
Singapore 695
Dublin 666
Frankfurt am Main 661
Wilmington 485
Jacksonville 464
Ashburn 458
Dearborn 435
Hong Kong 388
Seattle 363
New York 354
Milan 319
Santa Clara 276
Cambridge 268
Princeton 244
Nanjing 130
Altamura 122
Lawrence 117
Beijing 109
Shanghai 109
Lachine 79
San Diego 76
Nanchang 52
Helsinki 49
Jakarta 46
Andover 43
Guangzhou 42
Boardman 41
Dong Ket 38
Fremont 38
Hebei 36
Toronto 34
Shenyang 33
Tianjin 32
Falls Church 31
Lissone 31
Vienna 26
Rome 25
Ottawa 24
London 23
Monza 23
Jiaxing 22
Los Angeles 22
Munich 22
Nürnberg 20
Jinan 19
Kunming 19
Ningbo 19
Brno 18
Changsha 18
Norwalk 18
Brussels 16
Nuremberg 15
Hangzhou 14
Lentate sul Seveso 14
Zhengzhou 14
Cinisello Balsamo 13
Huizen 13
Philadelphia 12
Turin 12
Mountain View 11
Pune 11
Redmond 11
Moscow 10
Auburn Hills 9
Bergamo 9
Sacramento 9
Washington 9
Edmonton 8
Hefei 8
Lappeenranta 8
Limbiate 8
Padova 8
Sesto San Giovanni 8
Amsterdam 7
Bonndorf 7
Dallas 7
Desio 7
Genoa 7
New Delhi 7
Phoenix 7
Como 6
Detroit 6
Fuzhou 6
Lanzhou 6
Leawood 6
Romola 6
San Mateo 6
Taizhou 6
University Park 6
Bologna 5
Busto Arsizio 5
Carate Brianza 5
Caronno Varesino 5
Chicago 5
Cologno Monzese 5
Totale 13.252
Nome #
Pulse wave velocity progression over a medium-term follow-up in hypertensives: Focus on uric acid 301
Understanding Factors Associated With Psychomotor Subtypes of Delirium in Older Inpatients With Dementia 269
Serum uric acid, predicts heart failure in a large Italian cohort: search for a cut-off value the URic acid Right for heArt Health study 239
Hyperuricemia prevalence in healthy subjects and its relationship with cardiovascular target organ damage 216
Differing associations for sport versus occupational physical activity and cardiovascular risk 209
Clinical value of NT-proBNP assay in the emergency department for the diagnosis of heart failure (HF) in very elderly people 208
Prognostic value of ambulatory and home blood pressures compared with office blood pressure in the general population: follow-up results from the Pressioni Arteriose Monitorate e Loro Associazioni (PAMELA) study 206
Long-term risk of diabetes, hypertension and left ventricular hypertrophy associated with the metabolic syndrome in a general population 206
Clinical and prognostic value of hypertensive cardiac damage in the PAMELA Study 202
Association of uric acid with kidney function and albuminuria: the Uric Acid Right for heArt Health (URRAH) Project 201
Severe systemic cytomegalovirus infection in an immunocompetent patient outside the intensive care unit: a case report 199
Vitamin B12 deficiency-induced pseudothrombotic microangiopathy without macrocytosis presenting with acute renal failure: a case report 197
High normal blood pressure and left ventricular hypertrophy echocardiographic findings from the PAMELA population 193
Accuracy evaluation of the 'Cardiette BP one' ambulatory blood pressure monitor 191
The Pamela study: main findings and perspectives 191
Prevalence and clinical significance of a greater ambulatory versus office blood pressure ('reversed white coat' condition) in a general population 190
Left ventricular hypertrophy increases cardiovascular risk independently of in-office and out-of-office blood pressure values 187
Metabolic syndrome in the Pressioni Arteriose Monitorate E Loro Associazioni (PAMELA) study: daily life blood pressure, cardiac damage, and prognosis 185
Relationships between residual blood pressure variability and cognitive function in the general population of the PAMELA study 184
Alterations of cardiac structure in patients with isolated office, ambulatory, or home hypertension: Data from the general population (Pressione Arteriose Monitorate E Loro Associazioni [PAMELA] Study) 182
Long-term prognostic value of blood pressure variability in the general population: results of the Pressioni Arteriose Monitorate e Loro Associazioni Study 182
Serum uric acid and fatal myocardial infarction: detection of prognostic cut-off values: The URRAH (Uric Acid Right for Heart Health) study 181
The association between 24-h blood pressure patterns and left ventricular mechanics 180
Limited reproducibility of MUCH and WUCH: Evidence from the ELSA study 175
Prognostic relevance of electrocardiographic Tpeak-Tend interval in the general and in the hypertensive population: Data from the Pressioni Arteriose Monitorate e Loro Associazioni study 174
Relationships between diuretic-related hyperuricemia and cardiovascular events: data from the URic acid Right for heArt Health study 174
Combined effects of hypertension and hypercholesterolemia on radial artery function 172
Role of ambulatory blood pressure monitoring in resistant hypertension 167
Differential effects of enalapril-felodipine versus enalapril-lercanidipine combination drug treatment on sympathetic nerve traffic and metabolic profile in obesity-related hypertension 164
Comparison of the new alpha 1-blocker alfuzosin with propranolol as first-line therapy in hypertension 163
Relationship of office, home, and ambulatory blood pressure to blood glucose and lipid variables in the PAMELA population 159
Blood pressure variability and organ damage in a general population: Results from the PAMELA study 159
Is night-time hypertension worse than daytime hypertension? A study on cardiac damage in a general population: The PAMELA study 159
Uric Acid and New Onset Left Ventricular Hypertrophy: Findings From the PAMELA Population 159
Long-term risk of mortality associated with selective and combined elevation in office, home, and ambulatory blood pressure 158
The PAMELA (Pressioni Arteriose Monitorate E Loro Associazioni) study: Main features and results 155
Response to possible difference in the sympathetic activation on extreme dippers with or without exaggerated morining surge 154
Systolic vs diastolic blood pressure control in the hypertensive patients of the PAMELA population 153
Within-visit BP variability, cardiovascular risk factors, and BP control in central and eastern Europe: Findings from the BP-CARE study 153
Long-term Saxagliptin Treatment Improves Endothelial Function but not Pulse Wave Velocity and Intima-Media Thickness in Type 2 Diabetic Patients 153
Simultaneous validation of the SunTech 247 diagnostic station blood pressure measurement device according to the British hypertension society protocol, the international protocol and the association for the advancement of medical instrumentation standards 151
Total cardiovascular risk, blood pressure variability and adrenergic overdrive in hypertension: evidence, mechanisms and clinical implications 151
Differential value of left ventricular mass index and wall thickness in predicting cardiovascular prognosis: Data from the PAMELA population 151
Impact of different definitions of the metabolic syndrome on the prevalence of organ damage, cardiometabolic risk and cardiovascular events 150
Identification of the Uric Acid Thresholds Predicting an Increased Total and Cardiovascular Mortality Over 20 Years 150
Neuroadrenergic disarray in pseudo-resistant and resistant hypertension 149
Prognostic value of serum uric acid: new-onset in and out-of-office hypertension and long-term mortality 146
Multicentre randomised, double blind, evaluation of nebivolol plus HCTZ and irbesartan plus HCTZ in the treatment of systolic hypertension in the elderly: the NEHIS Study 146
New-onset left atrial enlargement in a general population 146
Do Combined Electrocardiographic and Echocardiographic Markers of Left Ventricular Hypertrophy Improve Cardiovascular Risk Estimation? 145
Do reverse dippers have the highest risk of right ventricular remodeling? 143
Diurnal blood pressure variation and sympathetic activity 142
HIV and metabolic syndrome - A comparison with the general population 141
Should white-coat hypertension in diabetes be treated? Pro 141
Normal values of left-ventricular mass: echocardiographic findings from the PAMELA study 141
Prognostic Significance of Left Atrial Enlargement in a General Population: Results of the PAMELA Study 141
Diagnosis and management of patients with white-coat and masked hypertension 139
Novel Antihypertensive Therapies: Renal Sympathetic Nerve Ablation and Carotid Baroreceptor Stimulation 138
Impact of body mass index and waist circumference on the cardiovascular risk and all-cause death in a general population: Data from the PAMELA study 138
The Pamela Study: Old and New Findings 136
Association between ADRA1A gene and the metabolic syndrome: candidate genes and functional counterpart in the PAMELA population 134
Sympathetic nerve traffic, insulin resistance and baroreflex control of circulation in patients with resistant hypertension 134
Nighttime Blood Pressure and New-Onset Left Ventricular Hypertrophy: Findings From the Pamela Population 133
Impact of demographic, anthropometric, haemodynamic factors on left atrial size in the general population: data from the PAMELA study 133
Relationship among morning blood pressure surge, 24-hour blood pressure variability, and cardiovascular outcomes in a white population 132
IMPORTANCE OF URIC ACID THRESHOLD IN ITS CORRELATION WITH METABOLIC SYNDROME 129
Ambulatory blood pressure in air traffic controllers 129
Prognostic value of "partial" and "true" white coat hypertension: data from 16 year follow-up in the PAMELA population 129
Blood pressure (clinic, home, 24-h) profiles and clinical correlates in 128
High heart rate amplifies the risk of cardiovascular mortality associated with elevated uric acid 128
Increased long-term risk of new-onset diabetes mellitus in white-coat and masked hypertension 126
Long-term prognistic value of white-coat hypertension: an insight from diagnostic use of both ambulatory and home blood pressure measurements 125
Impact of body mass index and waist circumference on the long-term risk of diabetes mellitus, hypertension, and cardiac organ damage 125
Adrenergic, metabolic, and reflex abnormalities in reverse and extreme dipper hypertensives 124
4C.07:Relationships between cognitive dysfunction, clinic and ambulatory blood pressure and blood pressure variability: results from the PAMELA Study 124
Prevalence and correlates of new-onset left ventricular geometric abnormalities in a general population: The PAMELA study 124
Exploration into Uric and Cardiovascular Disease: Uric Acid Right for heArt Health (URRAH) Project, A Study Protocol for a Retrospective Observational Study 124
C68 RESTING HEART RATE AND ARTERIAL STIFFNESS: A LONGITUDINAL PROSPECTIVE STUDY IN A POPULATION OF HYPERTENSIVE PATIENTS 122
Ambulatory monitoring of systolic hypertension in the elderly: Eprosartan/hydrochlorothiazide compared with losartan/hydrochlorothiazide (INSIST trial) 121
Predictive value of different indices of blood pressure variability on 121
Gender-related differences in serum uric acid in treated hypertensive patients fromcentral and east European countries: Findings from the blood pressure control rate and cardiovascular risk profile study 121
Serum uric acid and resistance to antihypertensive treatment: data from the European Lacidipine Study on Atherosclerosis 121
The importance of pulse pressure on cardiovascular risk and total mortality in the general population: Is sex relevant? 120
Long-term risk of sustained hypertension in white-coat or masked hypertension 119
Different neuroadrenergic activation and baroreflex function in resistant and pseudoresistant hypertension: a microneurographic study 119
Does QRS Voltage Correction by Body Mass Index Improve the Accuracy of Electrocardiography in Detecting Left Ventricular Hypertrophy and Predicting Cardiovascular Events in a General Population? 119
Hyperuricemia and Risk of Cardiovascular Outcomes: The Experience of the URRAH (Uric Acid Right for Heart Health) Project 119
Long-term changes in left ventricular mass echocardiographic findings from a general population 118
Hypertensive heart disease beyond left ventricular hypertrophy: Are we ready for echocardiographic strain evaluation in everyday clinical practice? 117
Clinic, home, 24-hour blood pressure profiles and clinical correlates in resistant hypertension: data from the PAMELA Study 113
Seasonal variations in home and ambulatory blood pressure in the PAMELA population 111
Risk of mortality in relation to an updated classification of left ventricular geometric abnormalities in a general population: The PAMELA Study 111
Adverse Prognostic Value of Persistent Office Blood Pressure Elevation in White Coat Hypertension 111
Aortic root diameter and risk of cardiovascular events in a general population: data from the PAMELA study 110
Right heart remodeling induced by arterial hypertension: Could strain assessment be helpful? 109
Comparative effects of candesartan and hydrochlorothiazide on blood pressure, insulin sensitivity, and sympathetic drive in obese hypertensive individuals: Results of the CROSS study 108
Short- and Long-Term Reproducibility of Nighttime Blood Pressure Phenotypes and Nocturnal Blood Pressure Reduction 108
Uric acid and risk of new-onsetmetabolic syndrome, impaired fasting glucose and diabetesmellitus in a general Italian population: data from the Pressioni ArterioseMonitorate E Loro Associazioni study 107
Arterial compliance in familial hypercholesterolaemia: A preliminary report 106
Cardiovascular Risk Associated With White Coat Hypertension: Pro Side of the Argument. 105
Totale 15.152
Categoria #
all - tutte 74.963
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 74.963


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/2020874 0 0 0 0 0 0 0 210 259 172 165 68
2020/20212.352 141 119 225 254 202 203 219 225 185 262 114 203
2021/20221.706 109 159 172 182 148 144 63 76 104 114 129 306
2022/20233.123 312 901 277 258 214 468 53 207 183 56 114 80
2023/20242.396 62 71 104 123 298 598 457 91 232 43 35 282
2024/20252.593 319 718 285 281 476 170 269 75 0 0 0 0
Totale 18.836